全文获取类型
收费全文 | 1087篇 |
免费 | 84篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 58篇 |
妇产科学 | 10篇 |
基础医学 | 143篇 |
口腔科学 | 22篇 |
临床医学 | 89篇 |
内科学 | 245篇 |
皮肤病学 | 22篇 |
神经病学 | 28篇 |
特种医学 | 79篇 |
外科学 | 158篇 |
综合类 | 20篇 |
预防医学 | 94篇 |
眼科学 | 23篇 |
药学 | 45篇 |
中国医学 | 1篇 |
肿瘤学 | 122篇 |
出版年
2023年 | 8篇 |
2022年 | 12篇 |
2021年 | 17篇 |
2020年 | 21篇 |
2019年 | 20篇 |
2018年 | 22篇 |
2017年 | 18篇 |
2016年 | 20篇 |
2015年 | 22篇 |
2014年 | 27篇 |
2013年 | 44篇 |
2012年 | 34篇 |
2011年 | 43篇 |
2010年 | 42篇 |
2009年 | 42篇 |
2008年 | 45篇 |
2007年 | 40篇 |
2006年 | 40篇 |
2005年 | 35篇 |
2004年 | 41篇 |
2003年 | 36篇 |
2002年 | 22篇 |
2001年 | 25篇 |
2000年 | 30篇 |
1999年 | 26篇 |
1998年 | 25篇 |
1997年 | 22篇 |
1996年 | 32篇 |
1995年 | 18篇 |
1994年 | 18篇 |
1993年 | 26篇 |
1992年 | 31篇 |
1991年 | 16篇 |
1990年 | 20篇 |
1989年 | 25篇 |
1988年 | 21篇 |
1987年 | 27篇 |
1986年 | 23篇 |
1985年 | 23篇 |
1984年 | 18篇 |
1983年 | 10篇 |
1982年 | 10篇 |
1981年 | 13篇 |
1980年 | 10篇 |
1979年 | 5篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1968年 | 4篇 |
1966年 | 4篇 |
1964年 | 4篇 |
排序方式: 共有1180条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Segregation analysis of leprosy in families of northern Thailand 总被引:4,自引:0,他引:4
Sixty-three families with multiple instances of leprosy were identified through a major leprosy treatment center in northern Thailand. Complex segregation analyses for single major genes or polygenic inheritance were performed using the maximum-likelihood routine POINTER to determine the most likely etiologic model of genetic susceptibility. Liability differences between men and women were considered in these models. When individuals were considered to be affected because they had any form of leprosy, a generalized major gene model with nearly dominant parameters on the liability scale, but additive penetrances, was found to be the most likely. When only those individuals who had tuberculoid forms of leprosy were considered to be affected, a recessive model was found to be the most likely; however, the discrimination between various models was poor. Further analyses are necessary to delineate genetic mechanisms to explain these apparently divergent results. In particular, methods of testing two locus models should be considered. 相似文献
5.
青蒿琥酯皮肤擦剂在小鼠和兔体内的药代动力学研究 总被引:1,自引:0,他引:1
将青蒿琥酯溶于苯二甲酸二甲酯,加适量氨酮制成皮肤擦剂。给兔脱毛后,皮肤涂抹此擦剂25mg/kg后,血药浓度达峰时间平均为2 h,峰浓度平均为1.80μg/ml。药物在兔体内平均驻留时间为3.54 h,清除半衰期约为2.46 h。给小鼠脱毛皮肤涂抹擦剂6.7,31.3和71.4 mg/kg,血药浓度在给药后0.5~4 h达高峰,峰浓度分别为0.82,2.05和7.11μg/ml,体内药物平均驻留时间为3.39,2.79及3.54 h,清除半衰期为2.35,1.93及2.45 h。可见,给兔及小鼠皮肤擦剂后,青蒿琥酯吸收良好,血药浓度维持时间较长。 相似文献
6.
Nina Singh Cheryl Wannstedt Lois Keyes Marilyn M Wagener Thomas V Cacciarelli 《Liver transplantation》2005,11(6):700-704
A vast majority of the transplant recipients are cytomegalovirus (CMV)-seropositive (R+). We sought to assess variables predictive of CMV infection, specifically in R+ liver transplant recipients. Study patients comprised 182 consecutive liver transplant recipients who survived at least 14 days after transplantation. Surveillance testing was used to detect CMV infection. Pre-emptive therapy was employed for the prevention of CMV disease, however, no antiviral prophylaxis was used for CMV infection. CMV infection developed in 32.5% (38 of 117) of R+ patients, 84.6% (33 of 39) of R-/D+, and 3.8% (1 of 26) of R-/D- patients. In R+ patients, Hispanic race (21.6% vs. 7.8%, P = 0.06), donor CMV seropositivity (73.7% vs. 45.6%, P = 0.005), and hepatocellular carcinoma (23.7% vs. 6.3%, P = 0.05) correlated with a higher risk of CMV infection. In a multivariate model, Hispanic race (OR: 3.5, 95% CI: 1.03-11.6, P = 0.045), donor CMV serostatus (OR: 4.0, 95% CI: 1.6-10.2, P = 0.003) and hepatocellular carcinoma (OR: 5.8, 95% CI: 1.6-20.5, P = 0.006) were all significant independent predictors of CMV infection. The aforementioned variables did not portend a higher risk of CMV infection in R-/D+ patients; donor CMV seropositivity overwhelmed all other risk factors in R- patients (P < 0.00001). In conclusion, CMV-seropositive liver transplant recipients at risk for CMV infection can be identified based on readily assessable variables. Preventive strategies may be selectively targeted toward these patients. 相似文献
7.
In vitro modulation of cisplatin cytotoxicity by sparsomycin inhibition of protein synthesis 总被引:1,自引:0,他引:1
Z Zylicz D J Wagener H van Rennes J M Wessels E van der Kleijn W J de Grip L A van den Broek H C Ottenheijm 《Journal of the National Cancer Institute》1987,78(4):701-705
Inhibition of protein synthesis can alter cellular responsiveness to the classical anticancer drugs. The in vitro response of Chinese hamster ovary (CHO) cells to cisplatin with or without sparsomycin (Sm) was studied with the use of [3H]leucine and [methyl-3H]thymidine incorporation and clonogenic assay. Pretreatment of exponentially growing CHO cells with 1 microgram Sm/ml for 3 or 5 hours decreased [3H]leucine incorporation by 20% and resulted in significant resistance to cisplatin (P = .005). Sm in a concentration of 10 micrograms/ml reduced [3H]leucine and [methyl-3H]thymidine incorporation after 3 hours by 92 and 84%, respectively, and resulted in potentiation of the cisplatin cytotoxicity (P = .004). This effect was the same in the case of nonproliferating cells (P = .005), while protection due to Sm (1 microgram/ml) was seen only during cell proliferation. Simultaneous incubation and postincubation with Sm proved to have much less or no potentiating effect on cisplatin. The mechanisms of both protection and potentiation are still not clear, but our data indicate that Sm is a promising drug for further studies on the modulation of the cancer cell response to classical anticancer drugs. 相似文献
8.
S B Kaye J Wanders M Clavel J Verweij M J Piccart J F Smyth W W Ten Bokkel Huinink D J Wagener I R Judson F Cavalli 《Annals of oncology》1992,3(5):406-408
A total of 91 eligible patients with metastatic cancer have been treated in a series of phase II trials of the novel pentacyclic pyrroloquinone, fosquidone. Tumour types were breast (24), ovary (25), head and neck (21) and melanoma (21). All patients, except those with melanoma had received prior chemotherapy. The drug was given intravenously as a 20 min infusion, at the dose of 120 mg/m2 on days 1 to 5 of a 3 week cycle. Treatment was well tolerated; the only significant side-effects being mild headaches and generalised musculo-skeletal pains. Response was assessed after 2 cycles of therapy. Only one patient (with head and neck cancer) achieved an objective partial response, lasting 6 weeks. A total of 12 patients demonstrated stable disease for a median duration of 15 to 20 weeks. Using this schedule of administration, fosquidone has no significant antitumour activity in this group of tumours. 相似文献
9.
10.